News

21st.BIO Secures GRAS Status for Innovative Protein Ingredient

21st.BIO Secures GRAS Status for Innovative Protein Ingredient

21st.BIO Achieves Self-Affirmed GRAS Status

21st.BIO is excited to share that it has achieved self-affirmed GRAS (Generally Recognized As Safe) status for its innovative, animal-free beta-lactoglobulin ingredient, known as BLG Essential+™. This important milestone allows the company’s customers to effectively launch their products in the U.S. market, leveraging the advanced technology developed by 21st.BIO.

Accelerated Market Entry for Customers

With an exceptional emphasis on rapid development, 21st.BIO enables its customers to move from the idea stage to market approval in less than two years. This remarkable speed is made possible by the company’s expertise in precision fermentation technology, which has been refined through years of dedicated research and development.

About BLG Essential+

At the core of this achievement is BLG Essential+™, a high-quality recombinant beta-lactoglobulin produced through careful scientific analysis of cow's milk protein variations. This unique protein stands out as one of the most concentrated sources of whey protein, renowned for its exceptional nutritional benefits and functional versatility.

Exceptional Nutritional Benefits

Beta-lactoglobulin is celebrated as a potent and nutrient-rich dairy protein. Its appeal is largely due to its impressive nutritional profile, which includes:

  • A remarkable 45% higher leucine content compared to traditional whey protein isolates, making it particularly beneficial for muscle synthesis.
  • Stability across various pH levels and heat tolerance, which makes it suitable for a wide range of product formulations, including clear protein drinks, dairy alternatives, and baked goods.

Given its unique properties, 21st.BIO expects that customers will incorporate BLG Essential+™ into a diverse selection of food products, ranging from bakery items to alternative dairy products and nutritional offerings designed for sports nutrition, weight management, and dietary support for the elderly.

Innovative Business Model for Collaboration

21st.BIO's distinctive business model sets it apart in the industry by providing a single market approval that allows multiple dairy protein suppliers to commercialize their own production of BLG Essential+™. By joining 21st.BIO’s specialized BLG program, customers gain access to advanced production strains and precision fermentation processes that evolve over time. This model facilitates a smooth transition from pilot batches to full-scale manufacturing.

A Commitment to Customer Success

Per Falholt, co-founder and CSO of 21st.BIO, states, “We provide our customers with access to technology and expertise they cannot find elsewhere.” Thomas Schmidt, co-founder and CEO, adds that the company aims to be more than just a technology provider; they see themselves as true partners in the product development journey. Their focus is on enabling customers to concentrate on application, business growth, and innovation rather than just completing projects.

Comprehensive Support for Product Development

21st.BIO streamlines the product development process by offering extensive support at every stage, including strain development, fermentation, purification, pilot production, and the regulatory approvals needed for market entry. The company is committed to expanding its offerings to include additional protein innovations for various industries, such as food, materials, and agriculture.

About 21st.BIO

Founded in 2020 and based in Copenhagen, 21st.BIO is dedicated to democratizing access to its leading precision fermentation technology, allowing companies worldwide to bring biotech innovations to market at an affordable cost. The founders recognized the financial challenges that often hinder the transition of innovations from development to commercial success, coining this issue the "valley of death." 21st.BIO's mission is to bridge that gap, ensuring that groundbreaking bio innovations can reach a wider audience.

With outstanding R&D capabilities and a team located in both Copenhagen and Davis, California, 21st.BIO is committed to advancing the global green transition. Their ongoing initiatives focus on optimizing and developing industrial production technologies for proteins and molecules that address current food and agricultural needs.

Frequently Asked Questions

What is GRAS status?

GRAS status indicates that a substance is deemed safe for consumption based on its historical use or scientific evidence, allowing manufacturers to bring products to market more quickly.

How does 21st.BIO's technology work?

21st.BIO employs precision fermentation technology to produce proteins like beta-lactoglobulin in an efficient and sustainable manner, utilizing advanced microbial strains and processes.

What products can incorporate BLG Essential+™?

This protein can be used in a variety of food products, such as protein drinks, dairy alternatives, baked goods, and nutritional supplements.

How does 21st.BIO support its customers?

21st.BIO provides extensive support, including access to technology, guidance on scaling production, and assistance with regulatory approvals to ensure successful product launches.

What is the benefit of using BLG Essential+™ over traditional whey proteins?

BLG Essential+™ offers a higher concentration of essential amino acids, especially leucine, and provides greater versatility in product formulation compared to traditional whey proteins.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 421

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 253

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 34

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 462

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 547

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

H.I.G. Realty Forms Innovative Partnership to Foster Growth

Updated Category News Views 271

H.I.G. Realty Collaborates with Queen Mary BioEnterprises H.I.G. Capital, a prominent global alternative investment firm with an impressive $67 billion in capital under management, has exciting news to share. They have entered a strategic partnership with Queen Mary BioEnterprises Innovation Centre, located in the bustling area of Whitechapel, London. This collaboration...

Continue Reading
Hycroft Mines Q2 Shows Stability and Expansion Plans

Updated Category News Views 28

Riding High with a Safety Record and Cash Reserves Hycroft Mining Holding Corporation isn't just treading water—they're swimming strong, closing out Q2 of 2026 with zero injuries and a whopping $220.5 million in the bank. No debt, zero accidents, and 1.4 million work hours without an incident—those are numbers you don't just stumble upon. This is a sign of a company...

Continue Reading
Exciting Collaboration Between Financial Associations for 2026

Updated Category News Views 235

Exciting Collaboration Between Financial Associations for 2026 Financial Executives International (FEI) and the Media Financial Management Association (MFM) have made a significant announcement about their 2026 Annual Conference. This event is set to be a landmark occasion as they will co-locate and co-brand the conference, bringing in financial leaders from across...

Continue Reading
Breakthrough in Gene-Editing Therapy Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 279

Revolutionary Gene-Editing Therapy for Hyperlipidemia Unveiled CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy In a groundbreaking announcement, CorrectSequence Therapeutics Co., Ltd. has reported a notable milestone in the medical field. The completion of dosing for the first...

Continue Reading
Socket Mobile's CaptureSDK 2.0 Revolutionizes Data Capture Solutions

Updated Category News Views 124

Socket Mobile Launches CaptureSDK 2.0 for Enhanced Data Capture Socket Mobile, Inc. (NASDAQ: SCKT), a prominent player in the data capture industry, has made a significant leap forward with the introduction of CaptureSDK 2.0. This robust software solution sets the stage for a new generation of efficient and cost-effective barcode scanners that promise to benefit both...

Continue Reading